Dale,one of the problems that you meet, IMHO, when you pontificating on the web about what the individual prices of health care stocks ought to be,( whether it be Vivus or PFE ), is that,IMHO, you lack the proper global perspective/context that is necessary to determine such prices. Let me explain:
-1) you failed to note that MUSE is being covered by >70% of health insurance plans including, in office testing, by Medicare.
PFE is being frequently nixed in it's coverage
Oregon: Message 5591143
Europe: Message 5435939
Germany: Message 5401979 ( P.S. If “ rich “ Germany won't cover it, what makes you think it's poorer sister ( brother?gg) states will? Think,Dale.)
VAHospital ( that's Uncle Sam ,gg): Message 5292178
Medicaid: Message 5443419
Then we have Humana, Aetna,Prudential I believe, etc., etc. Haven't kept tab on all of them but they are all falling into the same line and balking as to payment.
2) You have failed to take into account into the cost of Viagra the litigation costs from deaths/& crippling
plus the costs for screening for heart disease. These costs are staggering as several of the above posts have attested to that.
3) with health care costs slated for a steep rise in '98 you can rest assured that no insurance is going to jump on this bandwagon anytime soon:
These are just a couple of important points. And the market is beginning to see this.This is why PFE stock has been diving since the launch of Viagra.
investor.msn.com
For those who missed my last comprehensive report on PFE/Viagra, here is a reprint. Little has changed since then, and my forecasts so far have been proven correct.
Message 5100265
May I suggest to you Dale a more profitable year ahead by making a small investment in Eugene Braunwald's textbook of cardiology and , after carefully reviewing the section on coronary artery disease to proceed and short PFE every time it goes over 100?
Good luck,
TA
( PS Don't give your money to SGCowen: they may trying to unload their PFE, GG, IMHO. )
|
